Good day everyone, I want to talk about a couple of our recent reports, Citius Pharmaceuticals (CTXR) and Siyata Mobile (SYTA). We alerted CTXR on Mon...
Citius Pharmaceuticals (CTXR) Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-Cell Lymphoma
Citius Pharmaceuticals (CTXR) Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-C...
Is the Sell Off in Equities and Crypto Inflation Related or Just Year End Profit Taking and an Update on a Dynamic Bio Company
Is the Sell Off in Equities and Crypto Inflation Related or Just Year End Profit Taking and an Update on a Dynamic Bio Company New report coming at ma...
This junior gold miner has potentially massive gold reserves with a float of around 6M shares. Trading at less than half of a recently issued price target.
This junior gold miner has potentially massive gold reserves with a float of around 6M shares. Trading at less than half of a recently issued price ta...
We’re Keeping an Eye on Fed Policy and Want to Talk About a NASDAQ Company That Should Thrive in This Environment
We are overdue for a BIG WINNER and I think this next report will be just that! We will have this report ready for everyone tomorrow 12-2-21 near mark...
Siyata Mobile Inc. (NASDAQ: SYTA) Enters a Transformative Partnership with a NYSE Listed Distribution Partner that May Increase Revenues by Triple Digits
Siyata Mobile Inc. (NASDAQ: SYTA) Enters a Transformative Partnership with a NYSE listed distribution partner that May Increase Revenues by Triple Dig...
NASDAQ Company Offering a Buy the Dip Opportunity with a Major Catalyst Developing
Markets Struggling with “Uncertainty” and a NASDAQ Company Offering a Buy the Dip Opportunity with a Major Catalyst Developing New NASDAQ report to be...
For Those of us in the U.S.A. Happy Turkey Day! We Will be Back Next Week.
Be safe and enjoy your friends and family!
Our Report From October 14th, 2021 on Pasithea Therapeutics (NASDAQ: KTTA) is Providing 272% in Gains Today and is The Largest Gainer on The Entire NASDAQ Exchange
News out today: Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K. https://finance.yahoo.com/news/pasithea-therapeu...
Over 180% in Recent Bookable Gains. New Report Coming Monday 11-29-21 Near market Open.
A Company That is Continuing to Trend, Increasing Revenues, Forming New Partnerships and a Review of Two of Our November Reports Good day everyone, Ou...